.

What's Hot in Workers' Comp

TOP 10 DEVELOPMENTS IN PENNSYLVANIA WORKERS’ COMPENSATION IN 2023

What’s Hot in Workers’ Comp, Vol. 27, No. 12, December 2023

December 1, 2023

by Francis X. Wickersham

1.    An application for Fee Review is not premature on the basis that treatment is not related to the work injury where a Utilization Review Request has not been filed.
UPMC Benefit Mgmt. Servs., Inc. v. United Pharmacy Servs. (Bureau of Workers’ Comp. Fee Rev. Hearing Off.), 287 A.3d 474 (Pa. Cmwlth. 2022)

The claimant sustained a work injury to her lower back, which was accepted by a medical-only Notice of Compensation Payable. The employer denied payment of a prescribed cream on the basis that the treatment was not related to the injury. The pharmacy filed three applications for Fee Review, and the Fee Review Office denied each on the basis that the issue of causation to the work injury remained outstanding. The pharmacy requested a hearing and argued that the applications were not premature because the injury was accepted by the employer, no party petitioned for Utilization Review and the 30-day period to remit payment lapsed. The Hearing Office concluded that the causation defense was a challenge to the reasonableness and necessity of treatment, which should have been reviewed during the UR process. The Commonwealth Court affirmed this ruling, holding that the employer was obligated to dispute liability through the UR process to render the Fee Review applications premature. A dissenting opinion pointed out that the UR process was not intended to address causation-based challenges and the Fee Review applications were properly dismissed as premature. 

2.    An employer cannot take a credit for an overpayment of workers’ compensation benefits paid for one work injury against an award of benefits for a subsequent work injury.
Columbia Cnty. Commissioners v. Rospendowski, 286 A.3d 436 (Pa. Cmwlth. 2022)

Following a work injury, the claimant returned to work without a wage loss, and her benefits were suspended. However, the employer discovered the claimant had received an overpayment in wage loss benefits for her injury of over $10,000. The claimant suffered a second work-related injury eight years later, and the employer stated it would accept the injury as a medical injury only in order to recover the outstanding overpayment from the earlier injury. The court held that the employer was not entitled to the requested credit against the wage loss benefits for the later injury for the overpayment made relative to the earlier injury. 

3.    Commonwealth Court of Pennsylvania holds that injured workers may be reimbursed for medical cannabis used for treatment of a work injury.
Fegley v. Firestone Tire & Rubber, 291 A.3d 940 (Pa. Cmwlth. 2023)

The claimant was using medical marijuana to help with her chronic back pain for a work-related low back injury she sustained in 1997. A Utilization Review determination found that the medical marijuana was reasonable and necessary, and the claimant filed a penalty petition after not receiving reimbursement. The Commonwealth Court held that reimbursement of a claimant’s out-of-pocket expenses for medical marijuana usage to treat a work injury is required by the Act. The court also rejected the employer’s argument that Section 2102 of the Medical Marijuana Act (MMA) prevented them from paying for the injured workers’ medical marijuana. Section 2103 of the MMA specifies, “Nothing in the MMA shall require an employer to commit any act that would put the employer and any person acting on its behalf in violation of Federal law.” 

4.    Commonwealth Court of Pennsylvania again finds that an injured worker can be reimbursed for medical cannabis used for treatment of a work injury.
Appel v. GWC Warranty Corp., 291 A.3d 927, 929 (Pa. Cmwlth. 2023)

The claimant had sustained a lower back injury at work and underwent two surgeries. He used medical marijuana for his pain and sought reimbursement for his medical marijuana. The Workers’ Compensation Judge concluded that reimbursement was not required under Section 2102 of the Medical Marijuana Act (MMA), and the Appeal Board affirmed. The claimant argued that, although the MMA did not require coverage, it did not prohibit it either. The Commonwealth Court agreed and held that reimbursement for the claimant’s medical marijuana usage was required by the Act. The court again rejected an employer’s argument that they were prevented by Section 2102 of the MMA from paying for the injured workers’ medical marijuana. Section 2103 of the MMA specifies, “Nothing in the MMA shall require an employer to commit any act that would put the employer and any person acting on its behalf in violation of Federal law.”

5.    Supreme Court holds that the exclusivity provision of the Pennsylvania Workers’ Compensation Act precludes an employee bitten by a dog at work from filing a lawsuit against the employer for negligent acts and omissions. 
Franczyk v. Home Depot, Inc., 292 A.3d 852 (Pa. 2023)

The plaintiff was bit by a customer’s dog while working. The defendant allowed the dogs’ owners to leave the store prior to providing identifying information. The plaintiff filed suit against the defendant, claiming there was a failure to sufficiently investigate the incident and negligence in allowing the dogs’ owners and witnesses to leave the premises without obtaining necessary information. The Pennsylvania Supreme Court found that the plain language of the Act precludes a defendant’s liability beyond that provided by the Act. The court found that requiring litigation to continue on this issue would result in absurdities that the Act is meant to prevent. The court also held that permitting the suit would create perverse incentives for employees when injuries caused by a third party occur on the job and would place employers in a position to be faced with lawsuits by employees if third-party information is not obtained. 

6.    Supreme Court holds that a claimant’s dram shop claim arose out of the maintenance or use of a motor vehicle; therefore, the employer was precluded from subrogating its payment of Heart & Lung Act benefits against claimant’s settlement of the claim. 
Alpini v. WCAB, 294 A.3d 307 (Pa. 2023)

In this case, the claimant sustained multiple work-related injuries when his car was struck by an intoxicated driver. The employer accepted liability for the injuries and paid Heart & Lung Act (H&L) benefits to the claimant, and the claimant signed over his workers’ compensation wage loss benefits to the employer. The Pennsylvania Supreme Court considered whether an employer that paid H&L benefits was entitled to subrogation for a claim in which the claimant was injured and asserted both motor vehicle negligence- and Dram Shop Act-based claims. Section 1720 of the Motor Vehicle Financial Responsibility Law (MVFRL) precludes an employer from subrogating its payment of H&L Act benefits against a claimant’s third-party recovery in an action arising out of the maintenance or use of a motor vehicle. The court held that, based on a clear and unambiguous interpretation of Section 1720 of the MVFRL, the claimant’s action arose out of the maintenance or use of a motor vehicle. Because the action originated from the motor vehicle collision, the employer was precluded from subrogating its payment of H&L Act benefits against the claimant’s third-party settlement of his Dram Shop Act claims with the tavern owners. 

7.    Commonwealth Court holds that an award of specific loss benefits to a claimant who dies prior to payment is not payable to the estate where the cause of death is from the work injury.
Steets v. Celebration Fireworks, Inc., 295 A.3d 312 (Pa. Cmwlth. 2023)

The claimant sustained work injuries resulting from an explosion and subsequently was awarded specific loss benefits for the loss of use of both arms, with payments to begin once total disability benefits ceased. The claimant later passed away due to complications from a work-related respiratory deficiency. The claimant’s estate filed Petitions Seeking Payment of the claimant’s specific loss benefits and penalties for failure to pay previously awarded benefits. The Commonwealth Court held that precedent has established that the specific loss benefits may be paid following the death of an employee if the death is from a cause other than a work injury. The court also held that because the claimant’s death was related to the work injury, the employer’s only obligation under the Act was to pay $7,000 in funeral expenses. 

8.    A Hearing Officer in a Fee Review case does not have statutory authority to remedy an overpayment of medical bills made to the provider by the insurer.
Philadelphia Surgery Ctr. v. Excalibur Ins. Mgmt. Servs., LLC, 289 A.3d 157 (Pa. Cmwlth. 2023)

The Fee Review Section found that the provider was due $14,393.83 for medical services rendered to the claimant. The Hearing Office concluded that the Fee Review Section failed to acknowledge a prior payment made by the insurer to the provider and directed the provider to reimburse the insurer $39,838.05 as an overpayment. The provider appealed, and the Commonwealth Court granted the appeal on the grounds that the Hearing Office did not have the statutory authority to impose the remedy of reimbursement for an overpayment of medical services. Although the Hearing Office had the authority under the Medical Cost Containment Regulations to determine whether there was an underpayment or overpayment, Section 306(f.1)(5) of the Act establishes that the sole focus of the Fee Review process is the amount and/or timeliness of the payment from the employer or insurer; therefore, the reimbursement ordered was not proper. 

9.    An employer does not admit liability for a work injury with a late answer to a Claim Petition where the injury is not well pled.
Alvin Hollis v. C&R Laundry Services, LLC (WCAB), 299 A.3d 1086 (Pa. Cmwlth. 2023)

The claimant suffered injuries as a result of an August 6, 2019, motor vehicle accident while he was driving for the employer. A Claim Petition was filed, and in it, the claimant pled injuries of “left rotator cuff pathology, cervical left-side radiculopathy, and cervical, thoracic and lumbar sprain/strains.” Although a late answer was filed and a Yellow Freight motion granted, the opinion of the employer’s medical expert, that the claimant’s left shoulder tendinosis was not related to the work injury, was accepted and it was found that the claimant was recovered from a sprain and strain of the shoulder. The Workers’ Compensation Judge found “left rotator cuff pathology” was not a well-pled fact, not a medical diagnosis, and not legally sufficient or definitive of the shoulder injury. The Commonwealth Court affirmed, agreeing that “left rotator cuff pathology” was not well-pled, and the claimant was, therefore, not entitled to a presumption of ongoing disability related to his shoulder under Yellow Freight

10.    A January 2018 email sent by claimant to employer about emergency foot surgery he had in November 2017 was not sufficient notice of a work injury under the notice provisions of the Act. 
The Hershey Company v. Shawn Woodhouse (WCAB), 300 A.3d 529 (Pa. Cmwlth. 2023)

In this case, the claimant had a pre-existing history of diabetic neuropathy. He developed a right diabetic foot ulcer in June 2017. In November 2017, emergency foot surgery was performed. In January 2018, the claimant sent an e-mail notification to the employer about the surgery. The claimant returned to work in March 2018, but in April 2018, a below-the-knee amputation of his right leg was performed. In December 2019, the claimant filed a Claim Petition for specific loss benefits, alleging his work duties aggravated a diabetic foot ulcer. The petition was granted, which the employer appealed to the Commonwealth Court, arguing that notice was untimely since it was not provided until the Claim Petition was filed in December 2019. The Commonwealth Court agreed and reversed the decisions of the Workers’ Compensation Judge and the Appeal Board. The court noted that when the claimant testified, he admitted that he suspected his amputation was related to his job duties in 2017. According to the court, under Section 311 of the Act, the claimant was required to provide notice of the injury within 120 days of the date of his foot surgery. The court also found the claimant’s January 2018 email about the surgery insufficient for constructive notice under Section 312 of the Act, since it did not specify the surgery was work-related and that his job duties aggravated his pre-existing condition. 


 

What’s Hot in Workers’ Comp, Vol. 27, No. 12, December 2023 is prepared by Marshall Dennehey to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. We would be pleased to provide such legal assistance as you require on these and other subjects when called upon. ATTORNEY ADVERTISING pursuant to New York RPC 7.1 Copyright © 2023 Marshall Dennehey, all rights reserved. No part of this publication may be reprinted without the express written permission of our firm. For reprints or inquiries, or if you wish to be removed from this mailing list, contact tamontemuro@mdwcg.com.

Firm Highlights

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict.